Ruzexin 150 ,300 & 600 150mg, 300 mg & 600 mg FC tablet
PDF Leaflet Revision Date: 25 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of partial seizures and generalized tonic-clonic seizures in adults and children from 1 month.
Dosage (summary)
Adults: Initial 600 mg/day in 2 doses; maintenance 600-2400 mg/day. Children: 8-10 mg/kg/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
May cause serious birth defects; not recommended during breastfeeding.
Key Drug Interactions
- Hormonal contraceptives may be ineffective
- CYP2C19 substrates may have increased plasma levels
Contraindications
- Hypersensitivity to oxcarbazepine or excipients
Common side effects
- Somnolence
- Dizziness
- Hyponatremia
- Rash
Counselling Points
- Monitor for signs of hypersensitivity
- Use non-hormonal contraception
- Do not abruptly discontinue
Serious warnings
- Risk of serious skin reactions
- Risk of seizure aggravation
- Hyponatremia monitoring required
Important Disclaimer
The Ruzexin 150 ,300 & 600 150mg, 300 mg & 600 mg FC tablet professional information leaflet below is the property of Hetero Drugs South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
